| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 489 | 2020 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 367 | 2017 |
| Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy A Antinori, A Cingolani, L Alba, A Ammassari, D Serraino, BC Ciancio, ... Aids 15 (12), 1483-1491, 2001 | 271 | 2001 |
| Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts I Motta, R Centis, L D’Ambrosio, JM García-García, D Goletti, G Gualano, ... Pulmonology 26 (4), 233-240, 2020 | 254 | 2020 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 225 | 2020 |
| National institute for the infectious diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management E Nicastri, N Petrosillo, TA Bartoli, L Lepore, A Mondi, F Palmieri, ... Infectious disease reports 12 (1), 8543, 2020 | 225 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 219 | 2020 |
| Postmortem findings in Italian patients with COVID-19: a descriptive full autopsy study of cases with and without comorbidities L Falasca, R Nardacci, D Colombo, E Lalle, A Di Caro, E Nicastri, ... The Journal of infectious diseases 222 (11), 1807-1815, 2020 | 211 | 2020 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ... European Respiratory Journal 54 (6), 2019 | 186 | 2019 |
| Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases R Carsetti, S Zaffina, E Piano Mortari, S Terreri, F Corrente, C Capponi, ... Frontiers in immunology 11, 610300, 2020 | 184 | 2020 |
| Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment SA Joosten, KE van Meijgaarden, F Del Nonno, A Baiocchini, L Petrone, ... PLoS pathogens 12 (6), e1005687, 2016 | 158 | 2016 |
| Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy E Girardi, F Palmieri, A Cingolani, A Ammassari, N Petrosillo, L Gillini, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 26 (4), 326-331, 2001 | 143 | 2001 |
| IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis E Petruccioli, L Petrone, V Vanini, A Sampaolesi, G Gualano, E Girardi, ... Journal of Infection 66 (6), 475-486, 2013 | 133 | 2013 |
| Primary pulmonary hypertension in HIV patients: a systematic review AM Pellicelli, G Barbaro, F Palmieri, E Girardi, C D'Ambrosio, A Rianda, ... Angiology 52 (1), 31-41, 2001 | 132 | 2001 |
| A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients L Petrone, E Petruccioli, V Vanini, G Cuzzi, SN Fard, T Alonzi, C Castilletti, ... Clinical microbiology and infection 27 (2), 286. e7-286. e13, 2021 | 131 | 2021 |
| Tuberculosis and COVID-19 co-infection: description of the global cohort TB/COVID-19 Global Study Group European Respiratory Journal 59 (3), 2022 | 124 | 2022 |
| First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus E Petruccioli, T Chiacchio, I Pepponi, V Vanini, R Urso, G Cuzzi, ... Journal of Infection 73 (6), 588-597, 2016 | 123 | 2016 |
| Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB S Tiberi, MC Payen, G Sotgiu, L D'Ambrosio, VA Guizado, JW Alffenaar, ... European Respiratory Journal 47 (4), 1235-1243, 2016 | 119 | 2016 |
| Clinical review: new technologies for prevention of intravascular catheter-related infections S Cicalini, F Palmieri, N Petrosillo Critical Care 8, 1-6, 2003 | 119 | 2003 |
| Analytical evaluation of QuantiFERON-Plus and QuantiFERON-Gold In-tube assays in subjects with or without tuberculosis E Petruccioli, V Vanini, T Chiacchio, G Cuzzi, DM Cirillo, F Palmieri, ... Tuberculosis 106, 38-43, 2017 | 114 | 2017 |
